Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Rose Gubitosi-Klug, MD, PhD

Rose Gubitosi-Klug, MD, PhD

Office Locations

UH Westlake Health Center (15 mi.)

960 Clague Rd
Ste 1600
Westlake, OH 44145

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
8th Floor
Cleveland, OH 44106

UH Rainbow Babies & Children's Hospital (0 mi.)

11100 Euclid Ave
Ste 170
Cleveland, OH 44106

UH Landerbrook Health Center (7 mi.)

5850 Landerbrook Dr
Ste 220
Mayfield Heights, OH 44124

Biography: Rose Gubitosi-Klug, MD, PhD


  • Pediatric Endocrinology and Metabolism


  • Division Chief, Pediatric Endocrinology, Diabetes and Metabolism, UH Rainbow Babies and Children's Hospital
  • Division Chief, Pediatric Endocrinology, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • William T. Dahms Chair in Pediatric Endocrinology, UH Rainbow Babies & Children's Hospital

Certifications & Memberships

  • Pediatric Endocrinology - American Board of Pediatrics


Fellowship | Pediatric Endocrinology
Pediatric Endocrinology - University Hospitals Of Cleveland (2003 - 2006)

Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (2000 - 2002)

Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1999 - 2000)

Other Education
Washington University In St Louis (1999)

Medical Education
Washington University School Of Medicine In St Louis (1999)

Washington University In St Louis (1990)


Rose Gubitosi-Klug, MD, PhD, joined the faculty at Rainbow in 2006 and is currently the Chief of the Division of Pediatric Endocrinology, Diabetes and Metabolism, University Hospitals’ Rainbow Babies and Children's Hospital and Professor with tenure at Case Western Reserve University School of Medicine. Dr. Gubitois-Klug earned a B.S. in chemical engineering, summa cum laude, as a Langsdorf Fellow at Washington University in St. Louis in 1990.  She continued her studies at Washington University School of Medicine in the Medical Scientist Training Program, completing her MD and doctoral thesis in Neuroscience in 1999.  Dr. Gubitosi-Klug completed training in pediatrics and pediatric endocrinology at University Hospitals’ Rainbow Babies and Children’s.

Dr. Gubitosi-Klug’s clinical and laboratory research remain focused on the development, progression, and pathogenesis of the complications of diabetes, with the hopes of preventing these complications in her young patients. She is principal investigator of the Clinical Coordinating Center of the NIDDK-funded Epidemiology of Diabetes Interventions and Control Study (EDIC), the follow-up study to the landmark Diabetes Control and Complications Trial. This study is now in its 40th year!  She served as Vice Chair of the multicenter Treatment Options for Type 2 Diabetes in Adolescents and Youth Study (TODAY) and is the Chair of the new NIDDK-funded DISCOVERY Consortium with the goal of discovering risk factors for youth-onset type 2 diabetes. In her clinical practice, Dr. Gubitosi-Klug cares for general pediatric endocrine patients, but, in keeping with her research, has a special interest in patients with diabetes mellitus.

Featured Videos

Watch to find out more about this University Hospitals provider.

Related Blog Articles

Cameron celebrates his graduation with aunt and fellow Type 1 Diabetes patient Cindy Catalano

As Participants and Providers, We’re Pioneers in Diabetes Research

A groundbreaking diabetes study coordinated by UH Rainbow Babies & Children’s Hospital celebrates 40 years of impact around the world. Learn more.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Rose Gubitosi-Klug did not disclose any Outside Relationships with Industry.